Founded in 2016 and headquartered in Douglas, Isle of Man, KR1 is a venture capital firm focused on investing in early-stage European companies operating within the blockchain and digital asset sectors.

Agronomics is an investment firm specializing in biotechnology and biopharmaceuticals, with a focus on cellular agriculture and alternative proteins. It invests in both quoted and unquoted companies, and may participate in funds and other vehicles with exposure to the biopharma sector, including biotech-related debt. The firm seeks to create value by backing companies with the potential to generate substantial revenues from biopharmaceutical drugs and related technologies, pursuing opportunities across early to growth stages and, where possible, co-investing with experienced partners. It is based in the Isle of Man and formed to build a portfolio across biotechnology and biopharmaceuticals.

Founded in 2016, Atami Capital is a venture capital firm based in Douglas, Isle of Man. It specializes in early-stage to late-stage growth investments, typically ranging from £100k to £20 million. The firm prefers minority interests and works closely with management teams to create long-term value.

MissionOG is a Philadelphia-based venture capital and private equity firm that partners with high-growth business-to-business companies in fintech, financial services, data platforms, and software. It provides capital and leverages a broad network of industry experts to accelerate growth and guide portfolio companies toward strategic outcomes, including acquisitions. Founded in 2012, MissionOG is led by a team with experience in building and scaling companies through multiple growth stages. The firm focuses on early-stage and growth investments in sectors where it has operating expertise, including financial services, payments, software, and data-enabled technologies.

Juvenescence is a British Virgin Islands-based company focused on investing in human aging and longevity. It aims to extend both lifespan and healthspan by developing therapeutics that slow aging and treat age-related diseases. The company creates and partners with new ventures, in-licenses compounds, or forms joint ventures to build an ecosystem of assets targeting aging, regeneration, and related diseases.

LD Capital is a venture capital firm based in Beijing, China, specializing in value investing within the blockchain sector. As one of Asia's pioneering organizations in this field, it leverages its industrial resources and professional investment research teams to identify and invest in innovative projects. Notable investments include successful ventures in Qtum, Vechain, and Eos, which yielded significant returns. With teams operating across China, the United States, Europe, Singapore, Japan, and South Korea, LD Capital possesses extensive experience in traditional internet sectors, fintech, and advanced blockchain technologies. The firm is dedicated to promoting the globalization of blockchain and making quality investments across various domains, including finance, gaming, content publishing, and the Internet of Things. Through its efforts, LD Capital aims to enhance the infrastructure and overall development of the global blockchain ecosystem.

Founded by Viktor Prokopenya in 2012, VP Capital is a London-based investment firm focused on scaling and growing companies at the forefront of technology and innovation. It primarily invests in areas such as artificial intelligence and fintech.